ORG 31710

Drug Profile

ORG 31710

Latest Information Update: 08 Jan 2001

Price : $50

At a glance

  • Originator Organon
  • Developer Akzo Nobel; Organon
  • Class Antineoplastics; Antiprogestogens; Estrenes; Furans
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Induced abortion; Pregnancy

Most Recent Events

  • 08 Jan 2001 Discontinued-I for Pregnancy (Prevention) in Netherlands (PO)
  • 08 Jan 2001 Discontinued-Preclinical for Induced abortion in Netherlands (Unknown route)
  • 19 Jan 1999 Phase-I clinical trials for Pregnancy (Prevention) in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top